Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program
Auxilius Pharma has consolidated its funding of $1 Million for developing its lead asset, AUX-001, […]
NIH Approves Second Phase of Funding to Support IND-enabling Work for Ambulero Gene Therapy to Treat Vascular Disease
Ambulero is developing a first-in-class gene and cell therapy platform for treating serious vascular diseases […]
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Kate Therapeutics, a next-generation gene therapy company, today emerged from stealth mode with a $51 […]
Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases
Nido Biosciences, a clinical-stage company developing precision treatments for debilitating neurological diseases, emerged from stealth […]
NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
NewBiologix SA has launched today as a technology innovation company developing a proprietary and breakthrough platform […]
BRIM Plans to launch a New Funding Round to Accelerate Late-Stage Clinical Trial and Initiate a New Phase 2 Trial for Orphan Drug BRM424
BRIM Biotechnology, a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint […]
Gene & Cell Therapy Manufacturing Specialist Ascend Launches With Over $130M of Funding
Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, […]
Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine
Ossium Health, announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the […]
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
Aldena Therapeutics, a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the […]
Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients
Mezzion Pharma, a rare disease-focused pharmaceutical company, announced that it has secured nearly $40M USD […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more